Luka Doncic, the Los Angeles Lakers' star guard, is traveling to Europe to undergo specialized medical treatment for his Grade 2 left hamstring strain, aiming to expedite his return for the NBA playoffs. The injury, sustained during a game against the Oklahoma City Thunder, was initially expected to sideline him for the remainder of the regular season and potentially into the postseason. However, Doncic's decision to seek advanced treatments in Europe—including stem cell therapy and other cutting-edge options not available in the U.S.—could shorten his recovery timeline.
The Lakers, already dealing with the absence of Austin Reaves (out with an oblique injury), suffered a 134-128 loss to the Dallas Mavericks on Sunday. LeBron James led the team with 30 points, 15 assists, and nine rebounds, but the Lakers' offensive output was significantly diminished without their top scorers. Dallas rookie Cooper Flagg delivered a standout performance with 45 points, nine assists, and eight rebounds.
Doncic's agent confirmed that the decision to travel to Europe was made after consulting with Lakers doctors and his own medical team. Dr. Jesse Morse, a sports injury specialist, noted that treatments like stem cells and exosomes are commonly used in Europe and could potentially accelerate recovery if administered correctly. However, the risks of reaggravating the injury remain, particularly if Doncic returns too soon to the high-intensity environment of playoff basketball.
Meanwhile, Stephen A. Smith faced backlash for comments suggesting Doncic may have exaggerated his injury during a blowout loss. Smith later denied insinuating that the injury was fabricated, but fans and analysts pointed to his original remarks as evidence of skepticism. The Lakers' playoff hopes now hinge on LeBron James and role players stepping up, with Bronny James seeing increased minutes in recent games.